SCHEMBL17022241

SCHEMBL17022241

CCNC(=O)CNC(=O)CNC(=O)CS

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.41
FAAH O00519 1/20 0.40
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
KMT2A Q03164 2/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RAB9A P51151 1/20 0.33
GAA P10253 1/20 0.31
RECQL P46063 1/20 0.31
HDAC1 Q13547 2/20 0.31
HDAC10 Q969S8 2/20 0.31
HDAC6 Q9UBN7 2/20 0.31
MEN1 O00255 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
PSMB5 P28074 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3895083 0.90
SCHEMBL17177647 0.82 FAAH (0.47) MCL1FAAHMMP1MMP2MMP3
SCHEMBL13912379 0.81 ALDH1A1 (0.35) MCL1TSHRHSD17B10RECQLHDAC1
SCHEMBL15069929 0.81 TSHR (0.33) TSHRHSD17B10RECQLHDAC1HDAC10
SCHEMBL16802010 0.80 KMT2A (0.50) MCL1FAAHMMP1MMP2MMP3
SCHEMBL20960533 0.80 KMT2A (0.50) MCL1FAAHMMP1MMP2MMP3
SCHEMBL24198636 0.78 MCL1 (0.43) MCL1FAAHMMP1MMP2MMP3
SCHEMBL21153346 0.78 MCL1 (0.48) MCL1FAAHMMP1MMP2MMP3
SCHEMBL20960431 0.78 MCL1 (0.43) MCL1FAAHMMP1MMP2MMP3
SCHEMBL1493216 0.78 ALDH1A1 (0.41) FAAHKMT2AHSD17B10RECQLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550704-B2 Method for synthesizing radiopharmaceuticals using a cartridge FUTURECHEM CO., LTD. (KR) 2017-01-24 US disclosed
US-20150232392-A1 METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE FUTURECHEM CO., LTD. (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232392-A1 METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE ADCYAP1R1, PAICS, SSTR5 MCL1 3689/4885FAAH 549/4885MMP1 4233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.